Stay updated on Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.

Latest updates to the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed. The rest of the page content and history lists remain unchanged.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedNew revision entry v3.3.2 is added to the history and the previous v3.3.1 entry is removed.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry, v3.3.1, has been added to the record history, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe government funding lapse notice banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedThe new screenshot shows additional entries in the Record History with updated Study Status and Recruitment Status. It also notes changes to Contacts/Locations across versions.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference10%

Stay in the know with updates to Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.